vaccine


Malaysia fast-tracks vaccine deals as coronavirus cases surge

Malaysia fast-tracks vaccine deals as coronavirus cases surge

(ATF) Malaysia’s science, technology and innovation minister, Khairy Jamaluddin, recently wrote on social media that 2021 would be the country's "year of vaccination".As Singapore and Indonesia kickstarted their vaccination programmes earlier this month, Malaysia has invested 3 billion ringgit ($743 million) in three major Covid-19 vaccines to cover at least …

Continue reading

Chinese media launch negative attacks on foreign vaccines 

Chinese media launch negative attacks on foreign vaccines

(ATF) China’s state-run media is running a blitz of negative articles about foreign Covid-19 vaccines while touting its indigenously developed products as safer, more reliable and cheaper.While mostly developing countries have bought or ordered China’s three coronavirus vaccines – made by Sinovac Biotech, Sinopharm and CanSino Biologics – developed nations …

Continue reading

Chinese Covid-19 vaccine has lower success rate than expected: report

Chinese Covid-19 vaccine has lower success rate than expected:

(ATF) The coronavirus vaccine developed by China's Sinovac Biotech showed a general efficacy of less than 60% in its late-stage trial in Brazil, according to a report published in São Paulo on Monday.UOL, a news website, said the figure - which contradicts the official efficacy rate - was sourced from …

Continue reading

India approves first Covid-19 vaccine with nod to AstraZeneca: report

India approves first Covid-19 vaccine with nod to AstraZeneca: re

(Reuters) India's drug regulator on Friday approved a coronavirus vaccine developed by AstraZeneca and the University of Oxford for emergency use, two sources with knowledge of the matter told Reuters.The decision clears the vaccine's rollout in the world's second-most populous country which, after the United States, has the highest number …

Continue reading

Asia’s economic shot in the arm

Asia’s economic shot in the arm

(ATF) Never has the success of a medical innovation meant so much to the global economy.The efficacy, production and rollout of Covid-19 vaccines will be key drivers in new year trades as the progress of the virus that did so much damage to global markets in 2020 accelerates into 2021.More …

Continue reading

Vaccines to accelerate Asian economic recovery 

Vaccines to accelerate Asian economic recovery 

(ATF) Coronavirus vaccine developments have been a shot in the arm for global markets, and nowhere has that been more evident than in Asia-Pacific, where strong economic recovery, combined with a sense of control over the pandemic, have boosted investors sentiment. That said, some countries in the region will grapple …

Continue reading

China bonds revive amid new vaccine hope

China bonds revive amid vaccine hopes

(ATF) China credits climbed Monday for the first time in three days as the announcement of a third likely vaccine for coronavirus emboldened investors to take on riskier assets.The gain ended the benchmark ATF China Bond 50 Index’s longest run of declines since September. The slump had been spurred by …

Continue reading

UK adds third vaccine to list

UK adds third vaccine to list

(ATF) A third developer of a vaccine for Covid-19 has said its candidate drug has a high level of efficacy, further raising hopes of an end to a pandemic that’s spreading faster around the world as winter deepens.The announcement from the UK’s AstraZeneca comes as a US official said jabs …

Continue reading

Markets at record highs with eyes on vaccine, economic support

Markets near highs with eyes on vaccine, economic support

Asian shares climbed on Monday, with a broad regional index touching a record high on hopes for imminent coronavirus vaccines, but worries over the impact of economic lockdowns and uncertainty over U.S. stimulus capped gains.A top official of the U.S. government's vaccine development effort said Sunday that the first vaccines …

Continue reading

A global sigh of relief

A global sigh of relief

(ATF) Swiss pharmaceutical giant Pfizer said it’s ready to begin a delivery programme for its Covid vaccine in the US the day after a second treatment showed a high level of efficacy.The response from economists has been predictable.“There is light at the end of the tunnel,” said Gain Capital’s Fiona …

Continue reading